Tibet Cheezheng Tibetan Medicine Co., Ltd. (SHE:002287)
China flag China · Delayed Price · Currency is CNY
18.79
+0.10 (0.54%)
Nov 17, 2026, 3:04 PM CST

SHE:002287 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
2,2322,4152,3362,0402,0401,766
Other Revenue
0.930.932.195.554.634.06
2,2332,4162,3382,0452,0451,770
Revenue Growth
-6.54%3.34%14.32%0.02%15.49%19.22%
Cost of Revenue
410.17410.66419.55324.7325.52269.7
Gross Profit
1,8232,0051,9181,7201,7191,501
Selling, General & Admin
1,0801,2851,2801,1621,107986.35
Research & Development
8581.0366.7358.6355.0970.82
Other Operating Expenses
138.536.0934.7632.2629.4728.58
Operating Expenses
1,3041,4011,3821,2531,1921,084
Operating Income
519.05603.98536.7467.52527.71416.45
Interest Expense
-8.44-41.86-57.79-63.07-56.42-53.43
Interest & Investment Income
16.518.54.1941.9216.96340.33
Currency Exchange Gain (Loss)
-0.12-0.12-0.01-0.03-0.02-0.02
Other Non Operating Income (Expenses)
19.47-1.04-0.02-1.16-3.56-2.46
EBT Excluding Unusual Items
546.46569.47483.08445.19484.68700.88
Impairment of Goodwill
------15.77
Gain (Loss) on Sale of Investments
41.6366.37100.3237.07-37.0820.69
Gain (Loss) on Sale of Assets
4.457.38-0.320-0.07
Asset Writedown
-5.550.06-0.58-0.3-1.22-0.35
Other Unusual Items
138.6896.5763.43162.1472.8282.54
Pretax Income
725.68739.84646.24644.41519.2787.91
Income Tax Expense
96.7892.3764.8765.2449.5677.09
Earnings From Continuing Operations
628.9647.47581.37579.18469.64710.83
Minority Interest in Earnings
3.090.950.912.022.95.05
Net Income
631.99648.43582.28581.2472.54715.88
Net Income to Common
631.99648.43582.28581.2472.54715.88
Net Income Growth
3.19%11.36%0.19%22.99%-33.99%77.21%
Shares Outstanding (Basic)
567544530530530529
Shares Outstanding (Diluted)
567544530530530529
Shares Change
6.14%2.50%0.03%-0.05%0.21%0.12%
EPS (Basic)
1.111.191.101.100.891.35
EPS (Diluted)
1.111.191.101.100.891.35
EPS Growth
-2.78%8.64%0.15%23.05%-34.13%77.01%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
285.73576.63201.31458.5913.29909.35
Free Cash Flow Per Share
0.501.060.380.860.031.72
Dividend Per Share
0.6400.6300.3800.4800.3900.590
Dividend Growth
6.67%65.79%-20.83%23.08%-33.90%73.53%
Gross Margin
81.63%83.00%82.06%84.12%84.08%84.77%
Operating Margin
23.25%25.00%22.96%22.86%25.81%23.52%
Profit Margin
28.30%26.84%24.91%28.42%23.11%40.43%
Free Cash Flow Margin
12.80%23.87%8.61%22.42%0.65%51.36%
EBITDA
660.05739.51664.94552.96604.13476.77
EBITDA Margin
29.56%30.61%28.44%27.04%29.54%26.93%
D&A For EBITDA
141.01135.53128.2385.4376.4260.32
EBIT
519.05603.98536.7467.52527.71416.45
EBIT Margin
23.25%25.00%22.96%22.86%25.81%23.52%
Effective Tax Rate
13.34%12.48%10.04%10.12%9.54%9.78%
Revenue as Reported
2,2332,4162,3382,0452,0451,770